We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,481 results

  1. Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments

    Chronic prurigo (CPG) is a neuroinflammatory, fibrotic dermatosis that is defined by the presence of chronic pruritus (itch lasting longer than 6...

    Svenja Müller, Claudia Zeidler, Sonja Ständer in American Journal of Clinical Dermatology
    Article Open access 17 September 2023

  2. Neuer Therapieansatz gegen Prurigo nodularis

    Beate Schumacher in hautnah dermatologie
    Article 23 January 2024

  3. Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments

    Prurigo nodularis (PN), or chronic prurigo, is a distinct disease characterized by the presence of chronic pruritus and multiple localized or...

    Anthony Bewley, Bernard Homey, Andrew Pink in Dermatology and Therapy
    Article Open access 20 August 2022

  4. A systematic review of interleukin-31 inhibitors in the treatment of prurigo nodularis

    Background

    Prurigo nodularis (PN) is a neuroimmunological skin disease. Severe itching is the most challenging symptom which affects patients’ quality...

    Mohammad Ali Nilforoushzadeh, Nazila Heidari, ... Niloufar Najar Nobari in Inflammopharmacology
    Article 08 February 2024

  5. Comprehensive plasma cytokine and chemokine profiling in prurigo nodularis reveals endotypes in Type 2 inflammation

    Prurigo nodularis (PN) is a chronic inflammatory skin disease that is associated with variability in peripheral blood eosinophil levels and response...

    Hannah L. Cornman, Jaya Manjunath, ... Shawn G. Kwatra in Scientific Reports
    Article Open access 06 April 2024

  6. Antikörper bei Prurigo nodularis

    Martina Freyer in hautnah dermatologie
    Article 21 November 2022

  7. Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis

    Introduction

    Validated patient report tools for quantifying patient experiences of itch in prurigo nodularis (PN) are limited. This study aimed to...

    Shawn G. Kwatra, Danielle Rodriguez, ... Jorge Puelles in Dermatology and Therapy
    Article Open access 24 August 2023

  8. The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis

    Introduction

    Sleep is often disturbed in patients with prurigo nodularis (PN). To address the lack of validated patient-reported outcome (PRO)...

    Sonja Ständer, Fatoumata Fofana, ... Jorge Puelles in Dermatology and Therapy
    Article Open access 17 June 2023

  9. Therapie der chronischen Prurigo: Update und Perspektive

    Background

    Despite the high burden in patients with chronic prurigo (CPG), the first and so far only approved systemic therapy for this disease,...

    F. Witte, S. Ständer, C. Zeidler in Die Dermatologie
    Article 13 June 2024

  10. Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials

    Prurigo nodularis (PN) is a chronic inflammatory skin disease with intensely pruritic nodules. The LIBERTY-PN PRIME and PRIME2 phase 3 trials...

    Gil Yosipovitch, Nicholas Mollanazar, ... John T. O’Malley in Nature Medicine
    Article Open access 04 May 2023

  12. Prurigo

    Prurigo represents a group of dermatoses characterized by intense pruritus and papular and papular-vesicular lesions. It can be acute (when resulting...
    Daniel Lorenzini, Fabiane Kumagai Lorenzini, ... Sabrina Dequi Sanvido in Dermatology in Public Health Environments
    Chapter 2023

  13. Prurigo Nodularis onset during secukinumab treatment of psoriasis: a case report

    Background

    Secukinumab has been approved by the U.S. FDA and the European Medicines Agency for the treatment of moderate-to-severe plaque psoriasis...

    Qingqing Yang, Jiajie Lyu, ... Shengxiu Liu in Allergy, Asthma & Clinical Immunology
    Article Open access 05 July 2023

  14. Effectiveness of Dupilumab for Chronic Prurigo in Chinese Patients: A Real-World Case Series Study

    Background

    Treatment of chronic prurigo (CPG) is challenging. As an antagonist of IL-4R, dupilumab has shown effectiveness in treating CPG in several...

    Lu Wei, Mengting Yin, ... **a Dou in Clinical Drug Investigation
    Article 17 September 2023

  17. Eine unerwartete Entdeckung bei einer Patientin mit chronischer Prurigo

    We report on a 61-year-old woman with a sudden onset of itching and nodules on the skin for the last year. Chronic prurigo (CPG) was diagnosed. An...

    Elisabeth Steffens, Mustafa Kaplan, Elke Weisshaar in Die Dermatologie
    Article Open access 13 March 2023

  18. Update zur Therapie der chronischen Prurigo

    Chronic prurigo is an inflammatory dermatosis defined by the presence of chronic pruritus and single to multiple symmetrically distributed...

    Claudia Zeidler, Manuel Pedro Pereira, Sonja Ständer in Die Dermatologie
    Article 12 July 2022

  19. Pemphigoid nodularis associated with pembrolizumab in a lung cancer patient

    Mihiro Yamamoto, Takashi Hashimoto, ... Takahiro Satoh in European Journal of Dermatology
    Article 01 January 2023

  20. Dupilumab treatment of prurigo nodularis in an adolescent

    Mattia Giovannini, Francesca Mori, ... Cesare Filippeschi in European Journal of Dermatology
    Article 01 January 2021
Did you find what you were looking for? Share feedback.